RP

Recursion Pharmaceuticals

RXRX

Application

Clinical-stage drug discovery company whose AI platform spans phenotypic screening, generative small-molecule design and clinical development.

Total funding$478.9M

Market cap$1.9B

Employees600

Founded2013

HeadquartersSalt Lake City, USA

StatusPublic

Product

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

• Recursion OS Platform

  Drug-discovery platform combining automated cell-biology experiments with machine-learning models over the resulting data.

Closest alternatives 2

ILIsomorphic LabsPrivate · $2.7B raisedBoth are AI-native drug-discovery platforms — Recursion OS against Isomorphic's Drug Design Engine — named as rivals in Recursion's own 10-K.1 of 1 capabilityShared product typeNamed in filingFind drug candidates fasterCompareIMInsilico MedicinePublic · $4.3BBoth platforms screen and design drug candidates with AI/ML; Insilico's own HKEX prospectus names Recursion in its Competitive Landscape table.1 of 1 capabilityShared product typeSame scale bandNamed in filingFind drug candidates fasterCompare

Similar products 7

How this list is ranked ↗

CDChai DiscoveryPrivate · $3.8BRecursion OS and Chai Discovery platform do comparable work on drug discovery; both also serve buyers who need to find drug candidates faster; larger scale (private).1 of 1 capabilityShared product typeLarger scaleCompareCCradlePrivate · $103M raisedRecursion OS and Cradle do comparable work on drug discovery; both also serve buyers who need to find drug candidates faster; similar scale (private).1 of 1 capabilityShared product typeCompareOOwkinPrivate · $304.1M raisedRecursion OS and BiomarkerPlus do comparable work on drug discovery; similar scale (private); ships AI agent and data service rather than the same layer.1 of 1 capabilityDifferent layerCompareTATempus AIPublic · $12.4BRecursion OS and Tempus Lens do comparable work on drug discovery; larger scale (public); ships agent platform and application rather than the same layer.1 of 1 capabilityDifferent layerLarger scaleCompareGDGoogle DeepMindAcquiredRecursion OS and AlphaFold Server do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships application rather than the same layer.1 of 1 capabilityDifferent layerCompareNNVIDIAPublic · $5.1TRecursion OS and NVIDIA BioNeMo do comparable work on drug discovery; larger scale (public).1 of 1 capabilityShared product typeLarger scaleCompareHCHuawei CloudPrivateRecursion OS and EIHealth do comparable work on drug discovery; Huawei Cloud's scale not recorded.1 of 1 capabilityShared product typeCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Total funding

News reporting · Apr 2021

Pre-IPO financing reporting: $448.9M equity raised plus a $30M Bayer collaboration upfront payment (2021-04, ahead of Recursion's IPO). Corrects the previously recorded $600M.

Market cap

Third-party database · 27 Aug 2026

Refreshed against the listing's own page.

Employees

Regulatory filing · 31 Dec 2025

RECURSION PHARMACEUTICALS, INC. Form 10-K (Item 1, Human Capital), SEC, filed 2026-02-25, for the period ended 2025-12-31. Filing states: "Our team of close to 600 employees, comprising of life scientists...and computational and technical experts..." CIK 1601830.

Founded

Regulatory filing · 11 Sep 2026

FY2023 10-K: "Recursion was founded in 2013."

Revenue (TTM)

Regulatory filing · 30 Jun 2026

Trailing twelve months to 2026-06-30, added from two filings: FY2025 total revenue $74,681K (10-K) - six months to 2025-06-30 $33,968K + six months to 2026-06-30 $14,143K (10-Q filed 2026-08-05: "Total revenue 7,670 19,223 14,143 33,968") = $54,856K. Neither filing states the TTM figure itself.

Description

Regulatory filing · 25 Feb 2026

FY2025 10-K: "We have built an end-to-end, AI-native platform that spans biological discovery, small molecule design, and clinical development".

Open Recursion Pharmaceuticals in the directory

Something wrong here? Send a correction — quote this company id: recursion-pharmaceuticals.